4
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Metabolic effects of fenfluramine in animals and human volunteers

&
Pages 207-218 | Accepted 20 Oct 1978, Published online: 21 Aug 2008
 

Summary

The metabolic effects of fenfluramine were investigated in human volunteers and in rats to evaluate the possibility of its use as an alternative to the biguanides in the treatment of patients with maturity-onset diabetes mellitus. The results showed that, whereas in animals phenformin causes lactic acidosis and diminished metabolism of lactate, fenfluramine is without an effect on lactic acid metabolism. Overdosage of fenfluramine, however, caused respiratory inhibition in rats with retention of CO2 and diminished arterial concentration of oxygen. In human volunteers, fenfluramine caused a decrease in the glucose concentration in venous blood as well as in capillary blood after oral glucose intake. The decrease in free fatty acid concentration evoked by oral glucose was also smaller after premedication with fenfluramine. These results were confirmed in patients with maturity-onset diabetes, and it is suggested that fenfluramine could be a valuable alternative to the biguanides in such patients, particularly if they are obese.

Résumé

Les effets métaboliques de la fenfluramine ont été étudies chez des volontaires sains et chez le rat afin d'évaluer son emploipossible dans le traitement du diabète de la maturityé à la place des biguanides. Alors que laphenformine occasionne une acidose lactique chez l' animal et diminue le métabolisme du lactate, il a été montréque la fenfluramine est sans effet sur le métabolisme de l'acide lactique. Un surdosage en fenfluramine a occasioné cependant une inhibition de la respiration chez le rat accompagnée d'une rétention de CO2, et a diminué la concentration artérielle en oxygène. Chez le volontaire sain, la fenfluramine a causé une diminution de la concentration en glucose du sang veineux et du sang des capillaires après absorption orale d'une charge glucoseée. La diminution de la concentration des acides gras libres provoquée par la charge glucoseée fut également moindre après prémédication par la fenfluramine. Ces résultats ont été confirmés chez des patients souffrant de diabète de la maturityé, et tendent à montrer que, chez ces patients, surtout s'ils sont obèses, la fenfluramine pourrait constituer une thérapeutique de remplacement des biguanides.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.